Targeted therapy in bronchial asthma. Benralizumab: focus on patients using systemic glucocorticosteroids by N. P. Kniajeskaia, E. Kh. Anaev, A. A. Kameleva, E. V. Safoshkina, N. D. Kirichenko

Get full text

Omalizumab and modification of bronchial asthma natural course by N. P. Kniajeskaia, E. H. Anaev, A. S. Belevskiy, A. A. Kameleva, E. V. Safoshkina, N. D. Kirichenko

Get full text

Clinical and economic comparison of utilization of reslizumab, mepolizumab and benralizumab in the treatment of severe eosinophilic asthma by S. K. Zyryanov, S. N. Avdeev, D. A. Ivanov, M. V. Zhuravleva, N. P. Kniajeskaia, N. V. Matveev, N. A. Nenasheva, D. S. Fomina, M. Iu. Frolov

Get full text